Foghorn Therapeutics

(NASDAQ) FHTX

Current Price$4.34

Market Cap$260.63M

Since IPO (2020)-76%

5 Year-55%

1 Year-2%

1 Month-9%

Foghorn Therapeutics Financials at a Glance

Market Cap

$260.63M

Revenue (TTM)

$28.22M

Net Income (TTM)

$75.32M

EPS (TTM)

$-1.20

P/E Ratio

-3.69

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Price

$4.34

Volume

1,723

Open

$4.46

Price

$4.34

Volume

1,723

Open

$4.46

Previous Close

$4.44

Daily Range

$4.34 - $4.49

52-Week Range

$3.27 - $6.95

Dividend

$0.00

Beta (Volatility)

1.60 (High)

Price

$4.34

Volume

1,723

Open

$4.46

Previous Close

$4.44

Daily Range

$4.34 - $4.49

52-Week Range

$3.27 - $6.95

FHTX News

A medical professional using a microscope

Why Foghorn Therapeutics Blasted 55% Higher Today

Eric VolkmanDec 13, 2021

FHTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Foghorn Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

106

CEO

Adrian Gottschalk, MBA

Website

www.foghorntx.com

Headquarters

Cambridge, MA 02139, US

FHTX Financials

Key Financial Metrics (TTM)

Gross Margin

22%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

Return on Capital

-51%

Return on Assets

-34%

Earnings Yield

-27.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$260.63M

Shares Outstanding

58.70M

Volume

1.72K

Avg. Volume

146.72K

Financials (TTM)

Gross Profit

$27.58M

Operating Income

$82.11M

EBITDA

$78.78M

Operating Cash Flow

$86.10M

Capital Expenditure

$50.00K

Free Cash Flow

$86.15M

Cash & ST Invst.

$158.89M

Total Debt

$41.27M

Foghorn Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$3.27M

-45.1%

Gross Profit

$3.03M

-49.1%

Gross Margin

92.72%

N/A

Market Cap

$260.63M

N/A

Market Cap/Employee

$2.33M

N/A

Employees

112

N/A

Net Income

$19.88M

-5.5%

EBITDA

$21.57M

+2.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$142.89M

-23.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$40.13M

+55.9%

Short Term Debt

$1.86M

-79.6%

Return on Assets

-33.90%

N/A

Return on Invested Capital

-51.20%

N/A

Free Cash Flow

$25.27M

-5.3%

Operating Cash Flow

$25.27M

-5.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$7.78+0.91%

TRDAEntrada Therapeutics, Inc.

TRDAEntrada Therapeutics, Inc.$6.97+1.90%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$8.76-5.04%

ZURAZura Bio Limited

ZURAZura Bio Limited$4.66-2.73%

IMRXImmuneering Corporation

IMRXImmuneering Corporation$5.24+0.29%

PYXSPyxis Oncology, Inc.

PYXSPyxis Oncology, Inc.$2.75+0.36%

ENTAEnanta Pharmaceuticals, Inc.

ENTAEnanta Pharmaceuticals, Inc.$15.22-0.78%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.28-0.01%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$6.78-0.09%

MARAMara Holdings

MARAMara Holdings$13.63+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$17.00+0.09%

NOKNokia

NOKNokia$13.92+0.09%

NVDANvidia

NVDANvidia$219.36+0.02%

INTCIntel

INTCIntel$127.59+0.02%

Questions About FHTX

What is the current price of Foghorn Therapeutics?

Foghorn Therapeutics is trading at $4.34 per share.

What is the 52-week range for Foghorn Therapeutics?

Over the past 52 weeks, Foghorn Therapeutics has traded between $3.27 and $6.95.

How much debt does Foghorn Therapeutics have?

As of the most recent reporting period, Foghorn Therapeutics reported total debt of $41.99M.

How much cash does Foghorn Therapeutics have on hand?

Foghorn Therapeutics reported $88.91M in cash and cash equivalents in its most recent financial results.

What is Foghorn Therapeutics’s dividend yield?

Foghorn Therapeutics does not currently have a dividend yield.

Foghorn Therapeutics

Foghorn Therapeutics Financials at a Glance

FHTX News

Why Foghorn Therapeutics Blasted 55% Higher Today

FHTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Foghorn Therapeutics

FHTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Foghorn Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FHTX

What is the current price of Foghorn Therapeutics?

What is the 52-week range for Foghorn Therapeutics?

How much debt does Foghorn Therapeutics have?

How much cash does Foghorn Therapeutics have on hand?

What is Foghorn Therapeutics’s dividend yield?

Premium Investing Services